FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to investigate the safety and immunogenicity of the third vaccination with one of three different concentrations of a TBE vaccine in all subjects who completed two vaccinations in one of the three treatment groups of Baxter study 199 (a dose-finding study to investigate the safety and immunogenicity of two vaccinations with FSME IMMUN NEW in healthy subjects aged 1 to 6 years).
Epistemonikos ID: 32fbb4bbc06c447b9f00ecc4c10b44c45721bfc4
First added on: May 04, 2024